Author contributions: X.L.: conception and design, collection and/or assembly of data, data analysis and interpretation, and manuscript writing; J.Z.: conception and design, collection and/or assembly of data, and data analysis and interpretation; K.Z.: collection and/or assembly of data and data analysis and interpretation; T.J.K.: conception and design, manuscript writing, and final approval of manuscript; S.P.P.: conception and design, data analysis and interpretation, manuscript writing, and final approval of manuscript.
Embryonic Stem Cells/Induced Pluripotent Stem Cells
Article first published online: 25 FEB 2013
Copyright © 2012 AlphaMed Press
Volume 31, Issue 3, pages 447–457, March 2013
How to Cite
Lian, X., Zhang, J., Zhu, K., Kamp, T. J. and Palecek, S. P. (2013), Insulin Inhibits Cardiac Mesoderm, Not Mesendoderm, Formation During Cardiac Differentiation of Human Pluripotent Stem Cells and Modulation of Canonical Wnt Signaling Can Rescue This Inhibition. STEM CELLS, 31: 447–457. doi: 10.1002/stem.1289
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLSEXPRESS November 13, 2012.
- Issue published online: 25 FEB 2013
- Article first published online: 25 FEB 2013
- Accepted manuscript online: 29 NOV 2012 05:49AM EST
- Manuscript Accepted: 13 NOV 2012
- Manuscript Received: 30 AUG 2012
- NIH. Grant Numbers: R01 EB007534, R01 HL084615, U01 HL099773
- NSF. Grant Number: 0735903
- Canonical Wnt signaling;
- Insulin signaling;
- Human pluripotent stem cells;
- Cardiac mesoderm
The study of the regulatory signaling hierarchies of human heart development is limited by a lack of model systems that can reproduce the precise developmental events that occur during human embryogenesis. The advent of human pluripotent stem cell (hPSC) technology and robust cardiac differentiation methods affords a unique opportunity to monitor the full course of cardiac induction in vitro. Here, we show that stage-specific activation of insulin signaling strongly inhibited cardiac differentiation during a monolayer-based differentiation protocol that used transforming growth factor β superfamily ligands to generate cardiomyocytes. However, insulin did not repress cardiomyocyte differentiation in a defined protocol that used small molecule regulators of canonical Wnt signaling. By examining the context of insulin inhibition of cardiomyocyte differentiation, we determined that the inhibitory effects by insulin required Wnt/β-catenin signaling and that the cardiomyocyte differentiation defect resulting from insulin exposure was rescued by inhibition of Wnt/β-catenin during the cardiac mesoderm (Nkx2.5+) stage. Thus, insulin and Wnt/β-catenin signaling pathways, as a network, coordinate to influence hPSC differentiation to cardiomyocytes, with the Wnt/β-catenin pathway dominant to the insulin pathway. Our study contributes to the understanding of the regulatory hierarchies of human cardiomyocyte differentiation and has implications for modeling human heart development. STEM CELLS2013;31:447–457